SCHEMBL22223539

SCHEMBL22223539

c1ccc(-c2cc(-c3ccc(-n4c5ccccc5c5c6ccc7ccc8ccccc8c7c6ccc54)cc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.40
▸ KMT2A Q03164 6/20 0.40
▸ ALDH1A1 P00352 6/20 0.40
▸ HPGD P15428 6/20 0.40
▸ MEN1 O00255 5/20 0.40
▸ NTSR1 P30989 1/20 0.40
▸ KDM4E B2RXH2 5/20 0.37
▸ LMNA P02545 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ ATM Q13315 1/20 0.36
▸ PTGES O14684 2/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ CYP1A1 P04798 2/20 0.35
▸ CYP1B1 Q16678 2/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22211945 1.00 MAPT (0.40) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL21577617 0.95 KMT2A (0.43) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL13086753 0.95 KMT2A (0.43) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL17943397 0.94 KMT2A (0.42) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL22212007 0.93 ATM (0.39) MAPTKMT2AMEN1KDM4ELMNA
SCHEMBL19266949 0.92 MAPT (0.39) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL19428815 0.92 MAPT (0.39) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL22211946 0.91 HPGD (0.37) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL19428816 0.90 MAPT (0.37) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL19266946 0.90 MAPT (0.37) MAPTKMT2AALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11706981-B2 Organic light emitting device and compounds for use in same IDEMITSU KOSAN CO., LTD. (JP) 2023-07-18 — — US disclosed
US-11706981-B2 Organic light emitting device and compounds for use in same IDEMITSU KOSAN CO., LTD. (JP) 2023-07-18 — — US disclosed
US-20200227652-A1 ORGANIC LIGHT EMITTING DEVICE AND COMPOUNDS FOR USE IN SAME IDEMITSU KOSAN CO., LTD. (JP) 2020-07-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11706981-B2 Organic light emitting device and compounds for use in same SLCO4C1, XPO6, ERCC1 MAPT 485/4885KMT2A 3846/4885ALDH1A1 499/4885
US-20200227652-A1 ORGANIC LIGHT EMITTING DEVICE AND COMPOUNDS FOR USE IN SAME SLCO4C1, XPO6, ERCC1 MAPT 485/4885KMT2A 3846/4885ALDH1A1 499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback